US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

231.17

+0.46970.20%

Post-market: 231.350.1766+0.08%19:30 EDT

Volume:3K

Turnover:791.94K

Market Cap:463.85M

PE:- -

High:231.68

Open:231.68

Low:231.17

Close:230.70

52wk High:244.35

52wk Low:160.91

Shares:2.01M

Float Shares:2.01M

Volume Ratio:0.42

T/O Rate:0.17%

Dividend:0.95

Dividend Rate:0.41%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Amgen is Maintained at Equal-Weight by Wells Fargo

Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst

Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)

Political and General News Events from September 3

Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer

Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors

Buy Rating Reiterated on Daraxonrasib Strength, RASolve 301 Upsizing, and Unchanged $315 Price Target

Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan

NEJM publishes Phase 1/2 clinical data on daraxonrasib

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

Revolution Medicines Director Lorence H. Kim Disposes of Common Shares Worth $11.21 Million

Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares

Amgen to Present at Wells Fargo Healthcare Conference Webcast

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02

Regeneron Announces Q3 2026 Dividend of R$ 0.05 Per Unit

Political and General News Events from September 2

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BBH/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":231.1734,"timestamp":1789588800000,"preClose":230.7037,"halted":0,"volume":3421,"hourTrading":{"tag":"盘后","latestPrice":231.35,"preClose":231.1734,"latestTime":"19:30 EDT","volume":14,"amount":3236.4276,"timestamp":1789601405727,"change":0.1766,"changeRate":0.000764,"amplitude":0},"delay":0,"changeRate":0.002035944807127016,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"Not Yet Opened","change":0.4697,"latestTime":"09-16 16:00:00 EDT","open":231.68,"high":231.68,"low":231.1734,"amount":791940.974,"amplitude":0.002196,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":230.7037,"sharesOutstanding":1976503,"nav":230.79718,"aum":463095224.42,"dividendRate":0.004092,"bidAskSpread":0.001036,"preHourTrading":{"tag":"盘前","latestPrice":230.7037,"preClose":230.7037,"latestTime":"08:12 EDT","volume":2,"amount":461.4074,"timestamp":1789560753005,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":231.35,"preClose":231.1734,"latestTime":"19:30 EDT","volume":14,"amount":3236.4276,"timestamp":1789601405727,"change":0.1766,"changeRate":0.000764,"amplitude":0},"volumeRatio":0.42246,"impliedVol":0.1729,"impliedVolPercentile":0.239},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.42246,"shares":2006503,"dividePrice":0.9459,"high":231.68,"amplitude":0.002196,"preClose":230.7037,"low":231.1734,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":231.1734,"eps":0,"divideRate":0.004092,"volume":3421,"delay":0,"ttmEps":0,"open":231.68,"prevYearClose":189.2649,"prevWeekClose":229.3922,"prevMonthClose":236.396,"prevQuarterClose":203.2373,"fiveDayClose":231.22,"twentyDayClose":224.4799,"sixtyDayClose":189.3704},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665235617","title":"Amgen is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2665235617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665235617?lang=en_us&edition=fundamental","pubTime":"2026-09-05 02:47","pubTimestamp":1788547620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMGN/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWB","LU2361044949.HKD","BK4559","LU0128525929.USD","PJP","BBH","BK4534","LU0868494617.USD","LU0787776722.HKD","FTXO","LU0154236417.USD","LU0708994859.HKD","BK4533","LU2361044865.SGD","IBB","PGF","LU1894683348.USD","LU0640476718.USD","LU0130517989.USD","TBXU","LU1074936037.SGD","IBBQ","LU0942090050.USD","LU0130102774.USD","LU1069347547.HKD","LU0971096721.USD","LU0162691827.USD","LU1814569148.SGD","BK4588","LU1035773651.USD","LU1571399168.USD","BK4582","LU0417517546.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0175139822.USD","BIB","IE00BJT1NW94.SGD","IE0009355771.USD","LU0889565916.HKD","TFNS","LU1061106388.HKD","AMGN","LU0310799852.SGD","LU0742534661.SGD","PBE","IYF","IE0002270589.USD","LU0106831901.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664980438","title":"Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2664980438","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664980438?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:47","pubTimestamp":1788468476,"startTime":"0","endTime":"0","summary":"Regeneron director Kathryn Guarini disposes of 400 common shares worth $340,000Regeneron director Kathryn Guarini sold 400 shares on Sep. 2 at USD 850 per share.She exercised stock options for 400 sha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL9s8sKq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2106854487.HKD","LU0058720904.USD","IBBQ","LU2468319806.SGD","LU0320765992.SGD","LU2362541273.HKD","LU0823434583.USD","BK4139","LU0114720955.EUR","LU0823434740.USD","LU0053666078.USD","LU2089984988.USD","LU2237438978.USD","LU2362540622.SGD","IBB","BBH","LU2023250504.SGD","LU1917777945.USD","BK4588","TBXU","LU0109394709.USD","LU0882574055.USD","LU1974910355.USD","REGN","LU0889565916.HKD","LU0289739699.SGD","LU2362541513.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664012018","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2664012018","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664012018?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:35","pubTimestamp":1788467700,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 1.08% to $151.22 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.06% to 7,747.71 and the Dow Jones Industrial Average  rising 1.18% to 53,686.11.Gilead Sciences Inc. closed 3.86% short of its 52-week high of $157.29, which the company reached on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 1.17% to $278.43, Pfizer Inc.  fell 0.72% to $28.81, and Abbott Laboratories  fell 1.52% to $108.79.Trading volume  remained 2.3 million below its 50-day average volume of 6.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 3, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509010.AUD","LU1934455277.USD","LU2089984988.USD","BBH","LU0882574055.USD","IE00B3T34201.USD","LU0058720904.USD","LU2468319806.SGD","LU0889565916.HKD","IE00B19Z3B42.SGD","LU0823416689.USD","SG9999015945.SGD","LU1037948897.HKD","LU0109394709.USD","LU1037948541.HKD","LU1066053197.SGD","LU2087621335.USD","LU0234570918.USD","LU1057294990.SGD","TBXU","LU1674673428.USD","BMED","BK4583","BK4568","LU1430594728.SGD","IBBQ","LU1778281490.HKD","LU1674673691.USD","GILD","IE00BSNM7G36.USD","IE00B19Z3581.USD","LU0965508806.USD","IE0002270589.USD","LU1023059063.AUD","BK4532","IBB","BK4588","SG9999015978.USD","BIB","IE00BZ1G4Q59.USD","BK4578","LU0320765992.SGD","SG9999015986.USD","LU1934455194.USD","LU1061106388.HKD","MEDI","LU0965509101.SGD","LU2112291526.USD","LU2324357040.USD","TMED","LU0289739699.SGD","LU1571399168.USD","LU0965509283.SGD","BK4585","SG9999015952.SGD","LU0859254822.USD","LU1839511570.USD","LU0122379950.USD","LU0114720955.EUR","LU0861579265.USD","BK4139","LU1934455863.HKD","IE00BKVL7J92.USD","LU1066051498.USD","LU2357627491.SGD","BK4566","IE00B7SZLL34.SGD","BK4550","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664805389","title":"Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2664805389","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664805389?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:30","pubTimestamp":1788453034,"startTime":"0","endTime":"0","summary":"Gilead Sciences ($GILD) announced an update on their ongoing clinical study. Gilead Partner Study Marks Milestone in First-Line Stomach Cancer Ther...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gileads-arcus-backed-cancer-trial-reaches-completion-setting-up-a-key-immuno-oncology-catalyst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gileads-arcus-backed-cancer-trial-reaches-completion-setting-up-a-key-immuno-oncology-catalyst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4583","LU1023059063.AUD","SG9999015945.SGD","LU1674673428.USD","IBB","LU1778281490.HKD","LU0965508806.USD","LU1430594728.SGD","LU1585245621.USD","LU2089984988.USD","LU2112291526.USD","LU0058720904.USD","TBXU","LU2324357040.USD","LU0882574055.USD","LU1839511570.USD","LU1037948541.HKD","TMED","BMED","BK4139","LU0289739699.SGD","IE00B19Z3581.USD","LU1066051498.USD","IE00B3T34201.USD","LU1066053197.SGD","IBBQ","SG9999015952.SGD","LU0965509283.SGD","IE00BZ1G4Q59.USD","LU0965509101.SGD","LU1571399168.USD","LU2468319806.SGD","BIB","BK4588","LU1057294990.SGD","IE00B19Z3B42.SGD","LU1934455277.USD","SG9999015978.USD","LU0861579265.USD","LU1061106388.HKD","GILD","IE00BKVL7J92.USD","BK4566","BK4532","BBH","LU0122379950.USD","LU1934455194.USD","IE00B7SZLL34.SGD","LU0823416689.USD","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803700","title":"Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803700?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:04","pubTimestamp":1788451496,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has issued an update. Vortex Energy Corp. plans to launch a targeted ground gravity survey at its wholly owned ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-to-launch-ground-gravity-survey-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-to-launch-ground-gravity-survey-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","IE0002141913.USD","IE0009355771.USD","LU1093756168.USD","LU1674673691.USD","LU1430594728.SGD","SG9999001176.SGD","PBE","LU2237438978.USD","IE00B19Z9P08.USD","LU0417517546.SGD","IBBQ","GNMX","LU2236285917.USD","IE00BZ9MQY76.HKD","IE00B19Z3B42.SGD","BBH","TBXU","LU0320765992.SGD","IDNA","IBB","LU1069344957.HKD","VRTX","IE00B4R5TH58.HKD","LU2362540622.SGD","LU0058720904.USD","LU0079474960.USD","IE00B2B36J28.USD","LU2362541513.USD","BIB","LU0889565916.HKD","LU1035775433.USD","BK4585","IE00BJJMRZ35.SGD","BK4139","LU0061475181.USD","LU0109394709.USD","LU0234570918.USD","SG9999013999.USD","IE00BFTCPJ56.SGD","IE00B19Z9Z06.USD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU2324357040.USD","BK4532","LU2362541273.HKD","LU0823416689.USD","IE0002270589.USD","SGXZ57979304.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664704888","title":"Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664704888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664704888?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:10","pubTimestamp":1788444623,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Teva Pharmaceutical ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4557","LU0029874061.USD","BK4581","RVMD","BK4559","IE0009355771.USD","BK4585","IDNA","BK4584","LU1983299246.USD","TEVA","BK4596","XBI","LU0320765992.SGD","HCSG","IE00BJT1NW94.SGD","LU0128526141.USD","LU2324357040.USD","BK4007","XLV","LABU","BK4139","CANC","IE0009354923.USD","BK4566","BK4588","LU0889565916.HKD","PTH","BBH","BK4137","IE0002141913.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664741898","title":"Political and General News Events from September 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2664741898","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664741898?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:26","pubTimestamp":1788438361,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from September 3Sept 3 (Reuters)-For other diaries, please see:Political and General NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V0YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IBB","LU0889565916.HKD","BK4533","IE0009355771.USD","LU2089984988.USD","LU2112291526.USD","LU2242646821.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","TBXU","PBE","BK4139","IE00BFTCPJ56.SGD","BK4581","LU1571399168.USD","BK4585","BK4566","SG9999001440.SGD","BK4599","BK4534","LU0122379950.USD","LU0868494617.USD","AMGN","BK4588","LU1023059063.AUD","LU1983299246.USD","LU0109394709.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","IBBQ","LU1061106388.HKD","LU0289739699.SGD","LU0320765992.SGD","PJP","BIB","IE00B2B36J28.USD","LU2468319806.SGD","LU2242652126.USD","LU0058720904.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664487978","title":"Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664487978","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664487978?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:32","pubTimestamp":1788435147,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics names Ching-Pin Chang as chief scientific officerEikon Therapeutics named Ching-Pin “CP” Chang executive vice president, chief scientific officer.Chang joins from Bristol Myers Squi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL9l9Cns:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GILD","LU2087621335.USD","LU1291159041.SGD","IE00BN0W2V16.EUR","LU2133065610.SGD","FTXH","TMED","LU0109394709.USD","LU0122379950.USD","LU2242652126.USD","BK4550","LU1718418525.SGD","IE00BKPKM429.USD","IBB","BMY","IE00BQXX3D17.EUR","LU2125154778.USD","LU0114720955.EUR","LU2360032135.SGD","TBXU","LU0965509010.AUD","LU0859254822.USD","LU1983299246.USD","BBH","LU1093756325.SGD","BMED","IE00B64PRP62.GBP","LU2242646821.SGD","NDAQ","LU1236620834.HKD","EIKN","LU0306807586.USD","MEDI","LU2089984988.USD","LU1839511570.USD","BIB","LU1023059063.AUD","LU2095319765.USD","LU1934455194.USD","LU1585245621.USD","LU0321505868.SGD","LU1093756168.USD","IBBQ","IHE","SG9999014021.USD","LU0267386448.USD","BCDF","LU1057294990.SGD","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664482770","title":"Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664482770","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664482770?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:31","pubTimestamp":1788424260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 6.3% to 5.59 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25213.31.Sino Biopharmaceutical Ltd. closed 39% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 4.8% and Amgen Inc. remained unchanged.Trading volume totaled 127.7 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","BK4585","PJP","LU0868494617.USD","LU0109394709.USD","LU0122379950.USD","IE0002141913.USD","IE00BZ08YS42.EUR","IE0009355771.USD","AMGN","LU2242652126.USD","IE00BFTCPJ56.SGD","BK4533","LU0289739699.SGD","HK0000165453.HKD","IBB","BK1589","BK4588","IE00B4R5TH58.HKD","TBXU","IE00BJJMRZ35.SGD","LU1983299246.USD","BBH","BK4581","PBE","BK4566","LU1061106388.HKD","LU2242646821.SGD","IE00B2B36J28.USD","BK4534","01177","LU1571399168.USD","LU2089984988.USD","IE00BJT1NW94.SGD","IE00BZ08YT58.USD","LU2112291526.USD","LU0320765992.SGD","LU1023059063.AUD","LU0889565916.HKD","BK1515","BK1521","BK4139","BK4599","IE00BZ08YR35.GBP","SG9999001440.SGD","BK1191","IBBQ","LU0058720904.USD","LU1057294990.SGD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664828323","title":"Buy Rating Reiterated on Daraxonrasib Strength, RASolve 301 Upsizing, and Unchanged $315 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2664828323","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664828323?lang=en_us&edition=fundamental","pubTime":"2026-09-03 09:25","pubTimestamp":1788398717,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Charles Zhu maintained a Buy rating on Revolution Medicines yesterday and set a price target of $315.00. Charles Zhu has gi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-daraxonrasib-strength-rasolve-301-upsizing-and-unchanged-315-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-daraxonrasib-strength-rasolve-301-upsizing-and-unchanged-315-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","IE0009354923.USD","IDNA","IE0009355771.USD","IE00B4R5TH58.HKD","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","PTH","IE00B2B36J28.USD","RVMD","CANC","BBH","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4139","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664422868","title":"Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2664422868","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664422868?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:44","pubTimestamp":1788392661,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has shared an update. Vertex Minerals Ltd, an Australian minerals and resources company listed on the ASX as VTX...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-seeks-trading-halt-ahead-of-capital-raising-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-seeks-trading-halt-ahead-of-capital-raising-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0256863811.USD","BK4585","IE00B19Z9Z06.USD","LU1674673691.USD","LU0079474960.USD","IBBQ","GNMX","LU2236285917.USD","IE0009355771.USD","LU0823416689.USD","IE00B19Z9P08.USD","LU0320765992.SGD","LU2362541273.HKD","VERX","IE00B2B36J28.USD","SG9999013999.USD","LU2417539215.USD","BK4532","LU2237438978.USD","LU2362540622.SGD","LU2456880835.USD","IE0002141913.USD","VRTX","IE00B19Z3B42.SGD","IBB","BBH","LU0757428866.USD","LU0061475181.USD","IDNA","LU1430594728.SGD","MTX","BIB","PBE","SG9999001176.USD","SGXZ57979304.SGD","LU1559883803.SGD","IE00B4R5TH58.HKD","LU1585245621.USD","LU0432979614.USD","BK4023","IE00BFTCPJ56.SGD","LU2324357040.USD","TBXU","LU0109394709.USD","IE00BZ9MQY76.HKD","LU0889565916.HKD","LU0289739699.SGD","LU2362541513.USD","SG9999001176.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844659","title":"NEJM publishes Phase 1/2 clinical data on daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844659?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:55","pubTimestamp":1788386116,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) “announced that The New England Journal of Medicine has published a report describing data from the Phase 1/2 clinical ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nejm-publishes-phase-1-2-clinical-data-on-daraxonrasib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nejm-publishes-phase-1-2-clinical-data-on-daraxonrasib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BBH","IE0009354923.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE0002141913.USD","IDNA","CANC","LU0889565916.HKD","LU0109394709.USD","IE00B2B36J28.USD","PTH","RVMD","IE00BJT1NW94.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844613","title":"New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844613","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844613?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:50","pubTimestamp":1788385800,"startTime":"0","endTime":"0","summary":"Results support the clinical rationale for RASolve 301, an ongoing Phase 3 trial in RAS mutant metastatic non-small cell lung cancer REDWOOD CITY, Calif., Sept.  02, 2026 (GLOBE NEWSWIRE) --  Revoluti","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355564/0/en/new-england-journal-of-medicine-publishes-phase-1-2-clinical-data-on-revolution-medicines-rasonque-daraxonrasib-in-metastatic-non-small-cell-lung-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854104046.USD","BMED","LU0320765992.SGD","LU1854103824.USD","LU2360107325.USD","LU2298322129.HKD","NVIB","IE00BFMHRM44.USD","IE00BFTCPJ56.SGD","CANC","IE00BZ199S13.USD","LU1548497426.USD","LU1861220033.SGD","ONX","ON","BK4139","LU1861215975.USD","L","ONG","LU0053666078.USD","LU2487616109.SGD","IDNA","BBH","BK4605","BK4107","LU0109394709.USD","LU0724618433.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE0009354923.USD","LU0348723411.USD","IE00BJT1NW94.SGD","BK4512","IE00BD6J9T35.USD","LU1861219969.SGD","LU1983260115.SGD","RVMD","LU0124384867.USD","LU2357305700.SGD","BK4141","LU1720051017.SGD","PTH","GDOC","BK4585","BK4588","LU0889565916.HKD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","LU1978683503.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664984906","title":"Revolution Medicines Director Lorence H. Kim Disposes of Common Shares Worth $11.21 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664984906","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664984906?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:31","pubTimestamp":1788381115,"startTime":"0","endTime":"0","summary":"Revolution Medicines director Lorence H. Kim disposes of common shares worth $11.21 millionRevolution Medicines director Lorence H. Kim sold 56,000 common shares on Aug. 31 at about $200.56–$206.15.Sa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL1bnXL6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Director Lorence H. Kim Disposes of Common Shares Worth $11.21 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","PTH","BBH","IE00B2B36J28.USD","IDNA","IE00B4R5TH58.HKD","IE0002141913.USD","BK4139","LU0109394709.USD","CANC","IE0009354923.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","RVMD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664499688","title":"Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2664499688","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664499688?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:13","pubTimestamp":1788380002,"startTime":"0","endTime":"0","summary":"Gilead CEO Daniel O'Day disposes of USD 2.23 million in common sharesGilead Sciences Chairman and CEO Daniel Patrick O’Day sold 14,000 common shares on Sep. 1, 2026.Sales priced at about $147.51 to $1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5HTC5L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","LU0861579265.USD","LU0965509101.SGD","BBH","SG9999015952.SGD","LU1839511570.USD","TMED","IE00B19Z3B42.SGD","LU0859254822.USD","LU0965509010.AUD","LU2324357040.USD","IBBQ","IE00B7SZLL34.SGD","TBXU","LU0122379950.USD","IE0002270589.USD","LU0965508806.USD","LU1023059063.AUD","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU0889565916.HKD","BIB","LU0882574055.USD","MEDI","IE00BSNM7G36.USD","LU1934455277.USD","LU1061106388.HKD","LU0058720904.USD","BK4585","LU2087621335.USD","LU1057294990.SGD","LU2357627491.SGD","IBB","LU0320765992.SGD","SG9999015978.USD","IE00B19Z3581.USD","BK4568","LU0289739699.SGD","LU0109394709.USD","LU1934455194.USD","LU1585245621.USD","LU1571399168.USD","LU1674673691.USD","BK4583","LU1066051498.USD","BK4578","BMED","LU0965509283.SGD","LU0114720955.EUR","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664096846","title":"Amgen to Present at Wells Fargo Healthcare Conference Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2664096846","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664096846?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:01","pubTimestamp":1788379299,"startTime":"0","endTime":"0","summary":"Amgen to present at Wells Fargo Healthcare Conference webcastAmgen will present at the 2026 Wells Fargo Healthcare Conference on Sept. 10, 2026 at 11:00 a.m. ET.Speakers include CFO Thomas Dittrich, C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL9RK355:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","SG9999001440.SGD","LU0868494617.USD","IE0009355771.USD","LU0320765992.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","IBBQ","LU2242652126.USD","LU2112291526.USD","TBXU","BK4139","IBB","LU2089984988.USD","BK4566","BBH","LU1983299246.USD","LU1571399168.USD","LU0109394709.USD","PBE","LU2468319806.SGD","BK4581","AMGN","BIB","IE00B4R5TH58.HKD","BK4599","IE00BJT1NW94.SGD","LU0122379950.USD","LU0289739699.SGD","LU0058720904.USD","LU2242646821.SGD","LU1061106388.HKD","BK4534","LU1023059063.AUD","BK4533","BK4585","BK4588","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664784686","title":"NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02","url":"https://stock-news.laohu8.com/highlight/detail?id=2664784686","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664784686?lang=en_us&edition=fundamental","pubTime":"2026-09-03 02:45","pubTimestamp":1788374714,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-09-02Nasdaq 100.NDXTop PerformersPercent ChangeAlnylam Pharmaceuticals, Inc.ALNY.OQ+7.9%Regeneron Pharmaceuticals, Inc.REGN.OQ+3.5%PayPal Holdings, Inc.PYPL.OQ+3.4%NVIDIA CorporationNVDA.OQ+3.3%Keurig Dr Pepper IncKDP.OQ+3.3%Bottom PerformersPercent ChangePalo Alto Networks, Inc.PANW.OQ-10.6%Datadog IncDDOG.OQ-6.6%CrowdStrike Holdings, Inc.CRWD.OQ-6.5%Palantir Technologies Inc.PLTR.OQ-6.3%Fortinet, Inc.FTNT.OQ-5.4%The Nasdaq 100.NDXgained 12.41 points, or 0.04%, to 29,090.11 and recorded 2 new highs and no new lows. 49 stocks rose and 51 fell as declining issues outnumbered advancers by about a 1-to-1 ratio.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL8N44U25Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUG","NVDS.UK","NVC","LU2458330243.SGD","LU0444973449.USD","LU0198837287.USD","LU1718418525.SGD","IE00BDCRKT87.USD","LU0096362180.USD","LU0823434583.USD","LU0320765059.SGD","LU0823421416.USD","LU0251132253.USD","LU0472753341.HKD","LU1064131342.USD","LU0072462426.USD","SOXY","LU0342679015.USD","LU0053666078.USD","PSWD","LU2471134879.HKD","LU0476273544.USD","SG9999004303.SGD","LU0788109477.HKD","LU1935042215.USD","LU1244550577.SGD","BK4560","IE00BYXW3230.USD","LU2083900584.USD","QDEC","LU0708994859.HKD","PTIR","LU2750360997.AUD","FINX","LU0211327993.USD","LU2360106780.USD","LU2168564222.USD","FTEC","PALD","LU2361045086.USD","LU0719512351.SGD","LU2097344431.USD","SG9999014880.SGD","PYPY","VGT","ALNY","ABFL","DAT","IE00BK4W5L77.USD","LU0011850046.USD","LU0823414478.USD","LU0158827781.USD","LU2125909916.SGD","LU2468319806.SGD","QQQM","IXN","TQQQ","HK0000914686.HKD","WISE","IE00B19Z9Z06.USD","NVDO","07266","LU0823416689.USD","BK4533","IE00B19Z8W00.USD","SOXQ","LU0965509010.AUD","LU0345770308.USD","LU1989764664.SGD","SG9999015945.SGD","LU2106854487.HKD","BK4605","LU1989763690.USD","LU2452424414.USD","LU0215105999.USD","PBE","LU2087625088.SGD","LU1571399168.USD","NULC","SMHX","WCLD","LU2420271590.USD","LU0640476718.USD","BK4549","LU2168563687.JPY","AIPI","LU0949170772.SGD","LU0965509283.SGD","HK0000914660.USD","SG9999000418.SGD","LU0661504455.SGD","LU2746668974.SGD","IE00BKDWB100.SGD","NVD","HK0000306701.USD","LU0097036916.USD","SG9999001424.SGD","CLOD","SG9999018857.SGD","PSQ","LU2896262040.SGD","LU1732800096.USD","LU0323239441.USD","LU0724617625.USD","LU0225283273.USD","LU0238689110.USD","BK4532","IE00B3M56506.USD","SG9999014567.USD","LU1983260115.SGD","LU1861558580.USD","LU0417517546.SGD","LU0310800379.SGD","LU0353189763.USD","LU0130517989.USD","LU2347655073.USD","LU2272731600.USD","LU2362540622.SGD","IE00B4YYXB79.USD","LU0234572021.USD","NVYY","LU2471134796.USD","LU1280957306.USD","LU2294711713.HKD","LU0868494708.USD","LU2361044949.HKD","LU0096364046.USD","LU1169590202.USD","LU1400636574.HKD","QQQ","LU2326559502.SGD","LU1035775433.USD","02834","LU0106261372.USD","LU0882574139.USD","LU2087621335.USD","07522","LU2430703178.SGD","PLTW","LU0174119429.USD","LU2237443895.HKD","LU1868836591.USD","IE0009356076.USD","LU1127390331.HKD","LU2360107168.USD","GUNZ","LU2023251221.USD","LU0738911758.USD","LU0289961442.SGD","CRWD","LU0964807845.USD","LU2148611432.USD","LU0080751232.USD","LU2272731782.SGD","LU1119994496.HKD","LU2237957902.USD","LU2054465674.USD","LU1116320901.HKD","LU1791710400.SGD","BK4534","BK4579","IE0034235295.USD","LU0347712357.USD","LU0081259029.USD","LU2125909759.SGD","LU2286300806.USD","CRWC","LU1712237335.SGD","SNVDAmain","NAPR","LU1153585028.USD","LU1037948541.HKD","LU1261432733.SGD","LU1861559042.SGD","LU1923623000.USD","IE0004091025.USD","LU2403377893.USD","LU0029864427.USD","LU2237443382.USD","SNVD.UK","IE000Q6AESB8.SGD","IGV","LU1066051225.USD","LU2506951792.HKD","BK4588","LU0057025933.USD","BK4097","LU1852331112.SGD","NVDG","LU0234570918.USD","LU0170899867.USD","LU2213496289.HKD","NDX","LU0127658192.USD","LU0889565916.HKD","LU0211328371.USD","BK4503","LU1145028129.USD","07568","GPIQ","SGXZ81514606.USD","LU2756315664.SGD","2NVD.UK","LU2461242641.AUD","LU1144417596.USD","LU1366333091.USD","LU1989763427.SGD","LU1645745479.HKD","LU1003077747.HKD","LU0143551892.USD","LU2237438978.USD","LU1267930730.SGD","LU2458330169.SGD","LU2065171311.SGD","LU0726765562.USD","LU0787776722.HKD","IE00B1BXHZ80.USD","LU2433249047.HKD","SMH","IE00BJJMRY28.SGD","BK4581","IE00B19Z9P08.USD","LU1548497426.USD","LU1670756490.USD","LU0795875169.SGD","TRFK","SG9999015952.SGD","BK4561","LU2491050154.USD","BK4177","LU1435385759.SGD","FAI","LU2381873111.SGD","IBBQ","LU0107464264.USD","BK4524","IE00BJLML261.HKD","BK4585","LU0061475181.USD","LU0158827948.USD","LU1623119135.USD","LU0823434740.USD","IHAK","LU1400636657.SGD","LU0820562030.AUD","LU0957808578.USD","LU1815336760.USD","SG9999015986.USD","LU2357305700.SGD","IE00BJJMRX11.SGD","LU2250418816.HKD","LU1992135472.HKD","LU0094547139.USD","LU1935042991.SGD","STBQ","LU0353189680.USD","LU2430703251.USD","TBXU","SG9999014542.SGD","LU1721428933.USD","LU1839511570.USD","IE0034235188.USD","CIBR","NVDB","LU0265550946.USD","LU1720051017.SGD","DOGD","LU0980610538.SGD","LU2097344357.USD","IE00BZ1G4Q59.USD","LU0511384066.AUD","LU0942090050.USD","BK4554","LU2999663052.SGD","LU0528227936.USD","BK4567","LU1934455277.USD","LU2242649171.HKD","BK4551","IE00B19Z9505.USD","LU1066051811.HKD","BK4550","LU0133085943.USD","IE000YTNTUN2.SGD","IE00BKVL7J92.USD","LU2279689827.SGD","BBH","LU2322448957.HKD","LU1267930573.SGD","LU1629891620.HKD","LU1917777945.USD","IE00BMPRXR70.SGD","PALU","LU0545039389.USD","NVDS","LU1674673428.USD","IE00BZ199S13.USD","LU2462591277.SGD","LU0795875086.SGD","LU1732799900.SGD","LU0912757837.SGD","PLTI","LU2089984988.USD","LU2065170008.USD","LU2931357623.SGD","09388","LU0276348264.USD","LU0553294199.USD","BK4612","LU1804176565.USD","LU0256863902.USD","IE000KEQY171.SGD","LU0069063385.USD","LU0109391861.USD","LU0345769631.USD","GAMR","IE0001KFT4U8.USD","09834","LU1037948897.HKD","PANW","BK4614","09086","LU1880398471.USD","BK4543","PLTA","SG9999015358.SGD","LU0070217475.USD","CRWL","LU0882574055.USD","LU1674673691.USD","LU1699723380.USD","LU2111349929.HKD","BREW","BK4548","LU1429558221.USD","ROM","PLT","LU1244550221.USD","LU2357125470.USD","LU2746668461.USD","LU2089283258.USD","LU0048584097.USD","LU2413666699.HKD","LU1803068979.SGD","LU2360032135.SGD","NVDX","LU0210528500.USD","LU2290526834.HKD","LU2322448791.USD","SG9999015341.SGD","LU2237443978.SGD","LU0861579265.USD","LU2552382215.SGD","LU0316494557.USD","LU1242518931.SGD","LFGY","LU0310799852.SGD","LU0943347566.SGD","IE00BQXX3C00.GBP","LU2125154935.USD","09788","07788","BK4505","LU0138981039.USD","LU3102509885.SGD","LU1642822529.SGD","LU2028103732.USD","LU2347655156.SGD","NVII","LU1202635105.USD","SG9999002232.USD","ESUM","LU0689472784.USD","SPAM","IE00B19Z8X17.USD","EYES","HK0000306685.HKD","LU2637965513.SGD","LU2462157665.USD","LU1815333072.USD","LU0323240290.USD","IE00B5949003.HKD","LU2237443549.SGD","SGXZ99366536.SGD","LU1992135399.USD","LU1791807156.HKD","KDP","SG9999017495.SGD","LU0082616367.USD","LU1861220033.SGD","PLTL","JGRO","03086","AIFD","LU0210533765.USD","LU2552382132.HKD","IE00BK4W5M84.HKD","NVD2.UK","IE00BHPRN162.USD","PYPG","LU1232071149.USD","IE00B3S45H60.SGD","LU1914381329.SGD","IE0008368304.USD","IE00BFSS8Q28.SGD","LU2092627202.USD","TYLG","LU0175139822.USD","LU0708995401.HKD","IE00BJTD4V19.USD","LU2505996681.GBP","WCBR","LU1861127337.USD","LU0466842654.USD","LU0444971666.USD","LU0210536198.USD","HK0000304805.HKD","LU2750360641.GBP","LU2552382058.USD","TTXU","IE00BQXX3D17.EUR","LU2133065610.SGD","LU1979441026.SGD","LU0320765992.SGD","LU0203201768.USD","PLYY","NVDL","LU0289739343.SGD","BK4566","LU2077746001.SGD","LU1400636491.USD","LU1496350171.SGD","LU2100268510.USD","HK0000320223.HKD","LU0820561818.USD","IE00BZ9MQY76.HKD","SHLD","HK0000304797.USD","LU1551013425.SGD","LU1868836914.USD","LU1935043536.SGD","SG9999015978.USD","SG9999018865.SGD","LU0965509101.SGD","LU2210149790.SGD","NVDW","LU1814569148.SGD","NJAN","NJUL","IE00BQXX3F31.USD","BK4106","SOXX","CLOU","07261","CNEQ","IE00B5TLWC47.USD","LU1069347547.HKD","NVDQ","LU0154236417.USD","LU1066051498.USD","LU2063271972.USD","METV","SHOC","BK4607","LU0390134368.USD","LU2491050071.SGD","LU0267386448.USD","HK0000320264.USD","PLTU","PLTY","LU0642271901.SGD","LU2092937148.SGD","LU0274383776.USD","IE0003U64NQ7.SGD","LU0786609619.USD","LU1084165304.USD","LU0130102774.USD","USXF","IE00B3SWFQ91.USD","LU0308772762.SGD","NVIW.SI","CHAT","LU2023250330.USD","EFIV","IE00B775H168.HKD","LU0494093205.USD","LU2244417387.USD","LU1923622614.USD","LU2168564149.EUR","LU0979878070.USD","LU1934455863.HKD","LU0077335932.USD","QQQX","LU2487616109.SGD","IE00BWXC8680.SGD","TTEQ","LU0820561909.HKD","LU1923622291.USD","LU1066053197.SGD","LU1069344957.HKD","LU0477156953.USD","REGN","LU2756315318.SGD","IE00B894F039.SGD","LU1989772923.USD","LU2264538146.SGD","LU2505996509.AUD","SG9999014906.USD","BK4023","SGXZ80539844.SGD","SG9999014575.USD","IE00B775SV38.USD","LU2491049909.HKD","LU2860962120.EUR","LU1201861249.SGD","LU2125909247.SGD","LU0348723411.USD","DDOG","LU2168564495.EUR","QMAR","SPTE","IE000ITXATA3.USD","NVDA","IE00BJTD4N35.SGD","LU0265550359.USD","SG9999002224.SGD","IE0005OL40V9.USD","LU2543165471.USD","NVD3.UK","LU2089985449.USD","LU0187121727.USD","IE00B7KXQ091.USD","LU1989764748.USD","LU1935042488.USD","VT","BK4528","LU1720051108.HKD","LU0345768740.USD","BK4608","LU0266013472.USD","HAKY","LU1169589451.USD","SPLTRmain","BK4227","LU1633808545.USD","HK0000532082.HKD","SNPE","LU1988902786.USD","LU1691799644.USD","SGXZ31699556.SGD","LU1496350502.SGD","LU2065169927.USD","SG9999014559.SGD","PANG","BK4527","LU1861220207.SGD","DIPS","BK4613","LU1861215975.USD","03455","BK4587","LU1242518857.USD","LU1316542783.SGD","LU0823421333.USD","ARTY","LU1267930490.SGD","PLOO","LU2463028550.USD","LU2211815571.USD","LU2242650005.HKD","LU1989772840.SGD","LU0889565833.HKD","LU1934455194.USD","LU0354030511.USD","BK4598","LU2355687059.USD","ESLG","PYPU","TEK","IPAY","IE0034235303.USD","LU0006306889.USD","LU1323610961.USD","IE00BN29S564.USD","LU1935043023.USD","HK0000819398.USD","LU2471134952.CNY","LU0289960550.SGD","IE00BD6J9T35.USD","IE00BMPRXQ63.HKD","LU0058720904.USD","FDTX","SG9999014914.USD","LU1366192091.USD","LU1868837300.USD","LU0109392836.USD","IE00BKPKM429.USD","LU0672654240.SGD","THMR","LU0056508442.USD","IE00BMPRXN33.USD","LU2265009873.SGD","LU2362541513.USD","LU2394011477.USD","LU0109394709.USD","LU1821325948.USD","CHPX","LU2023250504.SGD","BK4139","NOCT","BK4141","LU2089284900.SGD","IE0004445015.USD","LU1244550494.USD","LU2471134523.USD","LU2271345857.HKD","XLK","IE00B4JS1V06.HKD","LU2047632596.USD","LU2456880835.USD","CMAG","PLTD","LU1868836757.USD","CLSE","IE00BFSS7M15.SGD",".IXIC","LU0557290698.USD","LU0683600562.USD","LU2602419157.SGD","LU2954938101.SGD","LU1974910355.USD","LU1861217088.USD","LU2247934214.USD","LU0957791311.USD","LU1791710582.SGD","LU0256863811.USD","LU1951200564.SGD","03034","LU0106831901.USD","LU0289739699.SGD","LU2592432038.USD","LU2430703095.HKD","SGXZ23171101.USD","LU2237957811.SGD","LU0868494617.USD","LU0114720955.EUR","LU2413666426.HKD","LU0323591593.USD","FTNT","LU0648001328.SGD","LU0157215616.USD","LU0345770993.USD","LU2237443622.USD","LU1880398554.USD","LU1778281490.HKD","07388","BK4547","SG9999014898.SGD","USD","LU2191332357.HKD","SQQQ","LU0965508806.USD","GNMX","LU0689626769.HKD","ILDR","NVDU","LU0345769128.USD","NVDD","3NVD.UK","LU2249611893.SGD","LU2272731865.HKD","PLTG","LU0345768153.USD","LU0124676726.USD","LU0128525929.USD","LU1668664300.SGD","LU2417539215.USD","LU0395794307.EUR","LU1035773651.USD","LU0079474960.USD","LU0823414551.USD","BK4535","LU2237443465.HKD","IE0004086264.USD","IBB","LU2360107671.USD","LU2361044865.SGD","IE00BDRTCR15.USD","SGXZ51526630.SGD","LU2023250843.SGD","LU1868837136.USD","LU2473716301.USD","LU0985320562.USD","LU2168564065.EUR","PLTR","LU2362541273.HKD","QID","BK4592","ANV","LU2236285917.USD",".HXC","GB00BDT5M118.USD","LU2108987350.USD","LU2095319765.USD","PYPL","LU2210150020.SGD","IE0009G5SDU7.USD","LU1551013342.USD","LU1951198990.SGD","IE00B1XK9C88.USD","LU2462591350.SGD","PLTZ","BK4529","LU0354030438.USD","TQQY","LU0061474705.USD","AGOX","IE0004445239.USD","LU0203202063.USD","LU1116320737.USD","LU2065171402.SGD","QLD","IE000W1ABFV2.USD","LU2125154778.USD","IETC","NVDY","LU0061474960.USD","LU2125909593.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664281843","title":"Regeneron Announces Q3 2026 Dividend of R$ 0.05 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2664281843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664281843?lang=en_us&edition=fundamental","pubTime":"2026-09-03 01:18","pubTimestamp":1788369530,"startTime":"0","endTime":"0","summary":"Regeneron announces Q3 2026 dividend of R$ 0.05 per unitRegeneron declared a 3Q 2026 dividend of R$ 0.05 per unit.Payment is scheduled for Sept. 4, 2026.Last day to trade with entitlement is Aug. 14, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbMY9NC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","LU0823416689.USD","LU0289739699.SGD","LU0109394709.USD","BK4588","LU2362540622.SGD","LU2106854487.HKD","LU0889565916.HKD","LU2362541513.USD","LU0320765992.SGD","BK4139","LU0823434740.USD","BK4585","LU2468319806.SGD","LU0058720904.USD","LU0053666078.USD","LU0882574055.USD","LU0114720955.EUR","REGN","IBB","TBXU","LU2023250504.SGD","LU2362541273.HKD","IBBQ","BBH","LU1974910355.USD","LU2089984988.USD","LU2237438978.USD","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664197218","title":"Political and General News Events from September 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2664197218","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664197218?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:08","pubTimestamp":1788350892,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from September 2Sept 2 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U10K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IE00B2B36J28.USD","LU0109394709.USD","LU0058720904.USD","BK4588","LU0868494617.USD","IE00B4R5TH58.HKD","TBXU","BK4581","LU0122379950.USD","IBB","IE0002141913.USD","IE0009355771.USD","PBE","LU2242652126.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","BK4599","LU0289739699.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","AMGN","LU0889565916.HKD","LU2112291526.USD","BBH","LU1983299246.USD","PJP","BK4534","IBBQ","LU1023059063.AUD","BK4139","BK4566","LU2089984988.USD","BIB","LU1061106388.HKD","LU1057294990.SGD","BK4585","LU1571399168.USD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381433","title":"Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381433","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381433?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:23","pubTimestamp":1788348209,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) has drawn fresh investor attention after two recent regulatory decisions. The FDA approved Bixlenvo for virologically suppressed adults with HIV, and the European Commission cleared Trodelvy plus Keytruda for certain metastatic triple-negative breast cancer patients.\nThese approvals arrive after a strong run in Gilead Sciences' stock, with a 30-day share price return of 15.14% and a year-to-date share price return of 23.29%, alongside a 36.48% 1-year total shareholder...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/is-gilead-sciences-gild-fully-valued-on-its-new-hiv-and-canc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/is-gilead-sciences-gild-fully-valued-on-its-new-hiv-and-canc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1023059063.AUD","LU0114720955.EUR","LU0965509101.SGD","LU1066053197.SGD","LU1061106388.HKD","BK4139","LU1585245621.USD","LU0289739699.SGD","BK4568","LU0122379950.USD","LU1778281490.HKD","LU0859254822.USD","TBXU","TMED","LU0965509283.SGD","IE0002270589.USD","LU2087621335.USD","LU2324357040.USD","IE00B3T34201.USD","BK4588","LU0058720904.USD","LU0823416689.USD","SG9999015986.USD","LU1037948541.HKD","SG9999015978.USD","GILD","LU1934455194.USD","SG9999015952.SGD","BMED","LU0889565916.HKD","IBB","LU1674673428.USD","LU1674673691.USD","LU2112291526.USD","BK4566","BK4585","BIB","LU0109394709.USD","IBBQ","LU0882574055.USD","BBH","BK4578","LU1934455863.HKD","BK4532","LU2089984988.USD","LU1066051498.USD","MEDI","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}